✦ LIBER ✦

A dual tyrosine kinase inhibitor lapatinib suppresses overexpression of matrix metallopeptidase 1 (MMP1) in endometrial cancer

✍ Scribed by Lin, Chiao-Yun; Chao, Angel; Wang, Tzu-Hao; Hsueh, Swei; Lee, Yun-Shien; Wu, Tzu-I; Chao, An-Shine; Huang, Huei-Jean; Chou, Hung-Hsueh; Chang, Ting-Chang; Lai, Chyong-Huey

Book ID: 125339507
Publisher: Springer
Year: 2014
Tongue: English
Weight: 812 KB
Volume: 92
Category: Article
ISSN: 0946-2716
DOI: 10.1007/s00109-014-1163-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of lapatinib a novel HER2 and E

Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells

✍ Konecny, G E; Venkatesan, N; Yang, G; Dering, J; Ginther, C; Finn, R; Rahmeh, M; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 234 KB

Lapatinib induces downregulation of matr

Lapatinib induces downregulation of matrix metallopeptidase 1 and deactivation of ERK1/2 and PI3K pathway in endometrial cancer

✍ C. Lai; C. Lin; A. Chao; S. Hsueh; T. Wang 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Lapatinib, a Dual ErbB-1/ErbB-2 Kinase I

Lapatinib, a Dual ErbB-1/ErbB-2 Kinase Inhibitor, in the Treatment of HER2-Overexpressing Locally Advanced and Metastatic Breast Cancer

✍ Susan R. Peck; Joyce A. O'Shaughnessy 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 95 KB

The growth inhibitory effect of lapatini

The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines

✍ Jin Won Kim; Hwang-Phill Kim; Seock-Ah Im; Soyeong Kang; Hyung Seok Hur; Young-K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Antitumor and antiangiogenic effect of t

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model

✍ Roque Diaz; Paul A Nguewa; Ricardo Parrondo; Carlos Perez-Stable; Irene Manrique 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 1019 KB

Inhibition of ErbB1 and ErbB2 by Lapatin

Inhibition of ErbB1 and ErbB2 by Lapatinib Ditosylate, a Dual Kinase Inhibitor: Promising Activity in Pretreated Advanced Breast Cancer

✍ Kavita Maung; Joyce A. O'Shaughnessy 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB